Author/Authors :
Whittaker، نويسنده , , Steven and Martin، نويسنده , , Matthew and Marais، نويسنده , , Richard، نويسنده ,
Abstract :
In this issue of Cancer Cell, She et al. show that in cancer cells a protein called 4E-BP1 is a key integrator of protein synthesis downstream of the ERK and AKT signaling pathways, providing an intriguing rationale for why their simultaneous targeting could enhance therapeutic efficacy.
